Regulation of Metastasis by microRNAs in Ovarian Cancer
Authors:
Open Access
- 10 June 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 4, 143
Abstract
Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detection methods. MicroRNAs (miRs) are small, non-coding RNAs that regulate gene expression post-transcriptionally. Accumulating data suggest central regulatory roles of miRs in modulating OC initiation, progression and metastasis. More recently, aberrant miR expression has been also associated with cancer stem cell (CSC) phenotypes and development of CSC chemo-resistance. Here, we review recent advances on miRs and OC metastasis and discuss the concept that miRs are involved in both CSC transformation and subsequent OC metastasis. Finally, we describe the prevalence of circulating miRs and assess their potential utilities as biomarkers for OC diagnosis, prognosis, and therapeutics.Keywords
This publication has 46 references indexed in Scilit:
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transitionJournal of Ovarian Research, 2013
- MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistanceJournal of Ovarian Research, 2013
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/NanogJournal of Biological Chemistry, 2012
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2Gynecologic Oncology, 2011
- Pelvic mass associated with raised CA 125 for benign condition: a case reportWorld Journal of Surgical Oncology, 2010
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?American Journal of Obstetrics and Gynecology, 2008
- Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothoraxEuropean Respiratory Journal, 2007
- Tumor Markers In Biological Fluids Associated With PregnancyCritical Reviews in Clinical Laboratory Sciences, 2007
- CA 125: The past and the FutureThe International Journal of Biological Markers, 1998